title: Motor development skills of 1- to 4-year-old Iranian children with early treated phenylketonuria.
abstract: Objective : To gauge the gross and fine motor development of early treated phenylketonuria (ETPKU) in children in the age range of 1-4 years. Methods : A cross-sectional analytic study was conducted in PKU clinics (reference clinics for PKU follow-up), Tehran, Iran. Seventy children with ETPKU were selected as the case group for the study. ETPKU children were those with early and continuous treatment with a phenylalanine-restricted diet (the mean of blood phenylalanine level during the recent 6 months was 2-6 mg/dL or 120-360 μmol/L). Also, 100 healthy and normal children matched with the ETPKU group for age were randomly selected from 4 kindergartens in four parts of Tehran as a control group. The measurements consisted of a demographic questionnaire, Peabody Developmental Motor Scale-2 (PDMS-2), and pediatrician assessment. Motor quotients were determined by PDMS-2 and then compared in both groups by two independent samples t-test. Results : The mean ages in case and control group were 28.5 (± 11.6) and 29.7 (± 11.3) months, respectively. Comparison of the mean fine, gross, and total developmental motor quotients (DMQs) showed statistically significant differences between the two groups (p < 0.05). The fine and total DMQs of ETPKU children were also correlated with age. In addition, there was a negative correlation between the phenylalanine level and fine (p < 0.001) and total (p = 0.001) DMQs. Conclusion : It seems that ETPKU Iranian children, regardless of following a phenylalanine-restricted diet or not, have lower motor development. It is recommended to plan programs for early detection and intervention of developmental delays in these children.
authors.affiliation: Occupational therapy Department, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
authors.forename: Sepideh
authors.initials: S
authors.lastname: Nazi
authors.forename: Farzaneh
authors.initials: F
authors.lastname: Rohani
authors.forename: Firoozeh
authors.initials: F
authors.lastname: Sajedi
authors.forename: Akbar
authors.initials: A
authors.lastname: Biglarian
authors.forename: Arya
authors.initials: A
authors.lastname: Setoodeh
references.citation: Acta Neurol Scand. 1992 Apr;85(4):243-8
references.pmid: 1316707
references.citation: J Neuropathol Exp Neurol. 1950 Jul;9(3):298-310
references.pmid: 15437204
references.citation: Mol Genet Metab. 2010;99 Suppl 1:S22-32
references.pmid: 20123466
references.citation: Mol Genet Metab. 2009 Apr;96(4):177-82
references.pmid: 19201235
references.citation: J Inherit Metab Dis. 2002 Feb;25(1):80-1
references.pmid: 11999985
references.citation: Mol Genet Metab. 2010;99 Suppl 1:S47-51
references.pmid: 20123470
references.citation: Dev Med Child Neurol. 2004 Apr;46(4):230-8
references.pmid: 15077700
references.citation: Rev Saude Publica. 2004 Apr;38(2):300-6
references.pmid: 15122388
references.citation: J Child Neurol. 2006 Nov;21(11):987-90
references.pmid: 17092471
references.citation: Acta Paediatr. 1998 May;87(5):565-70
references.pmid: 9641741
references.citation: Mol Genet Metab. 2007 Sep-Oct;92(1-2):63-70
references.pmid: 17591452
references.citation: Dev Med Child Neurol. 2005 Jul;47(7):443-8
references.pmid: 15991863
references.citation: Mol Genet Metab. 2008 Sep-Oct;95(1-2):17-20
references.pmid: 18703366
references.citation: Pediatr Phys Ther. 2012 Winter;24(4):345-52
references.pmid: 22965209
references.citation: Neuropsychol Rev. 2007 Jun;17(2):91-101
references.pmid: 17410469
references.citation: AJNR Am J Neuroradiol. 2001 Sep;22(8):1583-6
references.pmid: 11559511
references.citation: Acta Paediatr. 1995 Apr;84(4):411-5
references.pmid: 7795351
references.citation: J Inherit Metab Dis. 2009 Feb;32(1):46-51
references.pmid: 19191004